SUSRF Stock Financial Analysis - Surgical Science Sweden AB (publ) (OTCPK) Stock

Overview

Surgical Science Sweden AB, based in Sweden, operates within the healthcare sector, primarily focusing on the development and distribution of virtual reality simulators for medical training purposes. These advanced simulators are designed to provide hands-on learning experiences for students and professionals in various medical fields, notably in surgery and endoscopy, enhancing their skills without the risk of practicing on live patients. The company's main projects aim to push the boundaries of medical training technology by incorporating realistic, high-fidelity simulations that can replicate a wide array of medical procedures. This dedication not only helps in improving the educational landscape of surgical training but also significantly contributes to the advancement of patient safety by refining procedural skills before actual practice.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Surgical Science Sweden AB (publ) as of June 30, 2025 is 943.23 MM.
The operating income for Surgical Science Sweden AB (publ) as of June 30, 2025 is 140.89 MM.
The net income for Surgical Science Sweden AB (publ) as of June 30, 2025 is 92.45 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	943.23	140.89	92.45
2025-03-31	946.53	168.78	141.09
2024-12-31	884.09	144.32	131.65
2024-09-30	859.83	136.88	193.34
2024-06-30	838.25	151.76	197.72
2024-03-31	842.02	166.12	207.94
2023-12-31	882.85	189.15	233.97
2023-09-30	905.67	211.37	252.53
2023-06-30	900.50	193.42	233.63
2023-03-31	872.48	187.44	221.31
2022-12-31	802.54	156.86	187.97
2022-09-30	750.13	142.11	138.35
2022-06-30	640.37	127.92	124.21
2022-03-31	488.71	94.24	101.20
2021-12-31	366.78	82.97	86.25
2021-09-30	208.68	51.37	29.91
2021-06-30	138.29	30.84	21.49
2021-03-31	122.35	30.24	17.81
2020-12-31	104.80	21.37	15.61
2020-09-30	104.46	19.80	14.29
2020-06-30
2020-03-31

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31	2.58	2.58
2024-09-30	3.79	3.79
2024-06-30	3.87	3.88
2024-03-31	4.08	4.08
2023-12-31	4.59	4.59
2023-09-30	4.96	4.96
2023-06-30	4.60	4.59
2023-03-31	4.36	4.35
2022-12-31	3.70	3.69
2022-09-30	2.72	2.71
2022-06-30	2.53	2.52
2022-03-31	2.20	2.19
2021-12-31	2.03	2.02
2021-09-30	0.78	0.77
2021-06-30	0.60	0.59
2021-03-31	0.51	0.50
2020-12-31	0.45	0.45
2020-09-30	0.43	0.42
2020-06-30	0.56	0.55
2020-03-31	0.55	0.54

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Surgical Science Sweden AB (publ) as of June 30, 2025 is 90.02 MM.
The cash from investing activities for Surgical Science Sweden AB (publ) as of June 30, 2025 is -132.86 MM.
The cash from financing activities for Surgical Science Sweden AB (publ) as of June 30, 2025 is -1.12 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	90.02	-132.86	-1.12
2025-03-31	103.78	-132.71	-4.29
2024-12-31	137.22	-47.53	227.65
2024-09-30	120.15	-47.16	-3.42
2024-06-30	151.18	-50.71	-5.33
2024-03-31	206.30	-47.62	16.08
2023-12-31	238.29	-44.13	15.85
2023-09-30	277.25	-45.84	5.59
2023-06-30	233.58	-39.81	21.61
2023-03-31	178.90	-39.25	12.74
2022-12-31	129.49	-34.55	17.09
2022-09-30	37.90	0.66	15.58
2022-06-30	80.06	-2,623.98	2,631.05
2022-03-31	59.02	-2,618.94	2,623.60
2021-12-31	39.08	-2,732.61	2,922.46
2021-09-30	68.77	-2,755.47	2,922.98
2021-06-30	26.37	-122.74	295.58
2021-03-31	19.60	-122.07	297.71
2020-12-31	23.23	-8.69	4.21
2020-09-30	14.46	-10.14	3.29
2020-06-30
2020-03-31

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Management Effectiveness

The roa for Surgical Science Sweden AB (publ) as of June 30, 2025 is 0.03.
The roe for Surgical Science Sweden AB (publ) as of June 30, 2025 is 0.03.
The roic for Surgical Science Sweden AB (publ) as of June 30, 2025 is 0.03.
The croic for Surgical Science Sweden AB (publ) as of June 30, 2025 is -0.01.
The ocroic for Surgical Science Sweden AB (publ) as of June 30, 2025 is 0.02.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	0.03	0.03	0.03	-0.01	0.02
2025-03-31	0.03	0.03	0.03	0.07	0.03
2024-12-31	0.04	0.04	0.04	0.01	0.03
2024-09-30	0.04	0.04	0.04	0.02	0.03
2024-06-30		0.05
2024-03-31		0.06
2023-12-31			0.06	0.05
2023-09-30			0.05	0.05
2023-06-30		0.06
2023-03-31		0.06
2022-12-31
2022-09-30		0.00
2022-06-30		0.00	0.00
2022-03-31		0.00
2021-12-31		0.00	0.00
2021-09-30	0.07	0.07
2021-06-30	0.05		0.03	0.26	0.03
2021-03-31	0.04	0.04	0.02	0.26	0.03
2020-12-31	0.03	0.04	0.04	0.04	0.05
2020-09-30	0.03	0.04	0.03	0.02	0.03
2020-06-30	0.19	0.26	0.04	0.08	0.13
2020-03-31	0.17	0.23	0.04	0.07	0.11

Gross Margins

The gross margin for Surgical Science Sweden AB (publ) as of June 30, 2025 is 0.68.
The net margin for Surgical Science Sweden AB (publ) as of June 30, 2025 is 0.15.
The operating margin for Surgical Science Sweden AB (publ) as of June 30, 2025 is 0.18.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.68	0.15	0.18
2025-03-31	0.68	0.15	0.17
2024-12-31	0.69	0.22	0.17
2024-09-30	0.69	0.24	0.18
2024-06-30
2024-03-31
2023-12-31
2023-09-30		0.26	0.22
2023-06-30		0.26	0.22
2023-03-31		0.25	0.22
2022-12-31
2022-09-30		0.00	0.00
2022-06-30		0.00	0.00
2022-03-31
2021-12-31
2021-09-30
2021-06-30	0.84	0.16	0.21
2021-03-31	0.84	0.15	0.23
2020-12-31	0.84	0.15	0.19
2020-09-30	0.85	0.14	0.19
2020-06-30	0.85	0.17	0.21
2020-03-31	0.84	0.16	0.19

DE:4P41	€8.55
GB:0AAU	SEK94.63
SE:SUS	SEK97.00